Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.

It’s clear there’s a strong connection between sustained earnings growth and hall-of-fame returns. Keeping that in mind, here are three market-beating stocks that could turbocharge your returns.

Micron (MU)

Five-Year Return: +512%

Founded in the basement of a Boise, Idaho dental office in 1978, Micron (NASDAQ: MU) is a leading provider of memory chips used in thousands of devices across mobile, data centers, industrial, consumer, and automotive markets.

Why Are We Bullish on MU?

1. Annual revenue growth of 78.2% over the past two years was outstanding, reflecting market share gains this cycle
2. Excellent operating margin of 38.3% highlights the efficiency of its business model, and its rise over the last five years was fueled by some leverage on its fixed costs
3. Performance over the past five years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 43% outpaced its revenue gains

Micron’s stock price of $526.28 implies a valuation ratio of 5.4x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Vertex Pharmaceuticals (VRTX)

Five-Year Return: +100%

Founded in 1989 with a mission to create medicines that treat the underlying causes of disease rather than just symptoms, Vertex Pharmaceuticals (NASDAQ: VRTX) develops and markets transformative medicines for serious diseases, with a focus on cystic fibrosis, sickle cell disease, and pain management.

Why Does VRTX Stand Out?

1. Solid 14.1% annual revenue growth over the last five years indicates its offering’s solve complex business issues
2. Strong free cash flow margin of 24.4% enables it to reinvest or return capital consistently
3. ROIC punches in at 40.4%, illustrating management’s expertise in identifying profitable investments

At $427.20 per share, Vertex Pharmaceuticals trades at 22.6x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.

Permian Resources (PR)

Five-Year Return: +362%

Controlling roughly 450,000 net acres in America's most productive oil patch, Permian Resources (NYSE: PR) is an oil and natural gas producer that drills wells and extracts hydrocarbons from underground reservoirs in West Texas and New Mexico.

Why Will PR Outperform?

1. Impressive 43.3% annual revenue growth over the last ten years indicates it’s winning market share this cycle
2. Highly-profitable operating model results in strong unit economics and a best-in-class gross margin of 75.7%
3. Robust free cash flow margin of 27.2% gives it many options for capital deployment

Permian Resources is trading at $20.66 per share, or 10.7x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

Stocks We Like Even More

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.